A Comparison of the Prevalence of the Metabolic Syndrome among Sri Lankan Patients with Type 2 Diabetes Mellitus Using WHO, NCEP-ATP III, and IDF Definitions.

Herath Mudiyanselage Meththananda HerathN P WeerasingheThilak Priyantha WeerarathnaA Amarathunga

Published in: International journal of chronic diseases (2018)

The prevalence of MetS among patients with type 2 DM can significantly be varied based on the definition used and the three definitions of MetS recognized different set of individuals. The highest prevalence of MetS was observed with WHO (70.6%) whereas lowest was observed with NCEP-ATP III definition.

Keyphrases

risk factors
metabolic syndrome
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
cardiovascular disease
adipose tissue